The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.
about
Investigating Evolutionary Conservation of Dendritic Cell Subset Identity and FunctionsDeletion of parasite immune modulatory sequences combined with immune activating signals enhances vaccine mediated protection against filarial nematodesImmunogenicity of DNA vaccines encoding simian immunodeficiency virus antigen targeted to dendritic cells in rhesus macaquesEfficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.A novel method for synthetic vaccine construction based on protein assemblyDNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic.Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.Characterization of T-cell responses in macaques immunized with a single dose of HIV DNA vaccineA randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapyEngineering superior DNA vaccines: MHC class I single chain trimers bypass antigen processing and enhance the immune response to low affinity antigens.Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8+ T cells.Dendritic cell-based human immunodeficiency virus vaccine.The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cellsTargeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in miceTargeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacyIncreased generation of HIV-1 gp120-reactive CD8+ T cells by a DNA vaccine construct encoding the chemokine CCL3.Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL.In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in miceHeterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells.Newcastle disease virus expressing a dendritic cell-targeted HIV gag protein induces a potent gag-specific immune response in mice.DNA vaccines: ready for prime time?DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in miceTargeting DNA vaccines to myeloid cells using a small peptide.Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells.Designing the optimal vaccine: the importance of cytokines and dendritic cells.ESAT-6 Targeting to DEC205+ Antigen Presenting Cells Induces Specific-T Cell Responses against ESAT-6 and Reduces Pulmonary Infection with Virulent Mycobacterium tuberculosis.Codelivery of the chemokine CCL3 by an adenovirus-based vaccine improves protection from retrovirus infection.DEC205-DC targeted DNA vaccines to CX3CR1 and CCL2 are potent and limit macrophage migration.Genetic targeting of the active transcription factor XBP1s to dendritic cells potentiates vaccine-induced prophylactic and therapeutic antitumor immunity.Surface display of an anti-DEC-205 single chain Fv fragment in Lactobacillus plantarum increases internalization and plasmid transfer to dendritic cells in vitro and in vivoTargeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses.Targeting Dendritic Cells in vivo for Cancer Therapy.Dendritic cell functional improvement in a preclinical model of lentiviral-mediated gene therapy for Wiskott-Aldrich syndromeZnT8 is a major CD8+ T cell-recognized autoantigen in pediatric type 1 diabetes.The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.Microparticle surface modifications targeting dendritic cells for non-activating applications.Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes.Genetic Immunization With In Vivo Dendritic Cell-targeting Liposomal DNA Vaccine Carrier Induces Long-lasting Antitumor Immune Response.PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in miceA novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice.
P2860
Q26995456-D51C2981-D510-4B34-B2A1-C7F21FCDB738Q28484629-DE0FD96E-3C48-4F64-ADFC-406B53EDE7F1Q28728563-5F3AF357-0C40-4B7D-B93F-E71BEB40D0D7Q30204348-C9525FB0-1752-4A21-9F31-37FE12508A25Q30369012-D0B814F6-3E0A-4D67-A74C-6608F4143922Q31028199-8BAAECEB-7ABF-4231-BCA6-0C009740C9DCQ33489847-6BB12F12-DB12-4CA8-80A5-F59BB6B70030Q33614476-3F0428E5-14F2-4198-885D-1F8BFEEE5581Q33645564-AC397392-73D1-4808-B427-5358FBFB3F29Q33698112-BD6DD0B9-67F4-4A43-93DB-A94C797E06BAQ33732729-8FED8309-3845-4B00-A48F-915EA7EC0ED5Q33874652-749742A2-CE9E-474C-8BED-B4C7138C69E4Q33902379-FE8509E2-5F8E-4E79-8AE1-F312DC777CB8Q33989839-C1BDF129-BC04-4D8A-A532-032E3FC142B3Q34009407-9836225A-129A-4854-BCA7-5C20DA93DBF6Q34046807-7A347E99-AD0E-42B6-B3A6-A28B86B9A691Q34232224-A5245FF6-B23C-4B8F-87AE-7608C4ADB366Q34330250-0BDA345B-3E0B-48BB-84EC-50888FD0ECE1Q34428944-18BE6BC2-90D6-4C7C-AAA0-0918FCAEC22AQ34741882-8BE27ECE-1849-4823-A42E-7CAFBA675D0CQ34824179-7947A040-E9FD-4CBC-9FEB-BA2EF3EC7095Q34939255-0F44FD64-5B74-4B6F-BD5F-883B6EB88879Q34943809-16A33894-8FFE-438F-80D5-6FBEF5AB9692Q35139316-4137BE8C-6888-4A4F-8AE5-8546A2127711Q35146556-E5DE3248-BB6C-4BDB-9805-7C35A3EAAC02Q35542577-CFF2EA09-BE43-41E0-B601-1A7A048A85D0Q35689651-38BD8CF0-60EA-42C3-8F24-0ED0CDFBAE36Q35738533-8838C24B-19E1-4523-BC7C-96FCAD57B9F0Q35750026-D15CF7E6-3F6F-4832-A0AF-CBABEB88CAB2Q35816760-D919B0C8-4005-4A43-9ADE-4AA8CF5E64ABQ35826171-24CEACAC-3A04-4E5B-B04B-9385E65F5D81Q35928270-74A6C617-0D8F-466B-B822-D9A81BBA2C28Q36043410-5312E8D4-BE24-419D-9CDC-6A95658A77EAQ36047531-C6DA2A71-84DF-4863-B03E-BEFE866DE069Q36062758-4B356B6B-2C35-471D-8212-933848A423EAQ36191163-8B3A6263-076C-4690-BA54-F696B32C8ABCQ36718256-9283298A-85F3-46CA-9965-EE07AA4FDFF2Q36756884-28CB8236-FFB5-4F52-A10C-D3859F1DBC2FQ36890963-68895C5B-7FE4-4FB5-8D44-5EDE06FCE281Q37079131-C23A121B-E6FC-4A4A-9043-46A628E61FBC
P2860
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@ast
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@en
type
label
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@ast
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@en
prefLabel
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@ast
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@en
P2093
P2860
P356
P1476
The efficacy of DNA vaccinatio ...... ed protein to dendritic cells.
@en
P2093
Chae Gyu Park
Christine Trumpfheller
Drew Hannaman
Godwin Nchinda
Janelle Kuroiwa
Margarita Oks
Olga Mizenina
Ralph M Steinman
Sarah J Schlesinger
Yaoxing Huang
P2860
P304
P356
10.1172/JCI34224
P407
P577
2008-04-01T00:00:00Z